What is the Purpose of this Study?
The purpose of this study is to investigate the long-term effects of treatment with the medication terazosin on imaging exams in a population of 15 subjects with defined pre-motor Parkinson`s disease (PD) risks (i.e., REM Behavior Disorder (RBD) and at least one among hyposmia, constipation, depression and color vision abnormality) and an abnormal heart tracer uptake measured by the MIBG test.
Eligibility
- Enrolled in the study "The Effect of alpha1- adrenergic receptor antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease" (STUDY #000540)
- Capacity to give informed consent
Where can I participate?
Beverly
More about this Clinical Trial
What is the full name of this clinical trial?
The Effect of alpha1- adrenergic receptor antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson?s Disease: A Follow up study